Literature DB >> 17673654

Emerging challenges in regulatory T cell function and biology.

Shimon Sakaguchi1, Fiona Powrie.   

Abstract

Much progress has been made in understanding how the immune system is regulated, with a great deal of recent interest in naturally occurring CD4+ regulatory T cells that actively engage in the maintenance of immunological self-tolerance and immune homeostasis. The challenge ahead for immunologists is the further elucidation of the molecular and cellular processes that govern the development and function of these cells. From this, exciting possibilities are emerging for the manipulation of regulatory T cell pathways in treating immunological diseases and suppressing or augmenting physiological immune responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17673654     DOI: 10.1126/science.1142331

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  94 in total

1.  Prostaglandin E2 Reverses the Effects of DNA Methyltransferase Inhibitor and TGFB1 on the Conversion of Naive T Cells to iTregs.

Authors:  Mehmet Sahin; Emel Sahin
Journal:  Transfus Med Hemother       Date:  2019-09-19       Impact factor: 3.747

2.  T-cell signaling and immunopathologies.

Authors:  Christopher E Rudd
Journal:  Semin Immunopathol       Date:  2010-06       Impact factor: 9.623

Review 3.  The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities.

Authors:  Zhi Huang; Aaron H Rose; Peter R Hoffmann
Journal:  Antioxid Redox Signal       Date:  2012-01-09       Impact factor: 8.401

4.  CD4+ CD25+ but not CD4+ Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis.

Authors:  Dandan Wang; Huayong Zhang; Jun Liang; Zhifeng Gu; Qiang Zhou; Xiangshan Fan; Yayi Hou; Lingyun Sun
Journal:  Cell Mol Immunol       Date:  2010-08-23       Impact factor: 11.530

5.  Inhibition of S-phase kinase-associated protein 2 (Skp2) reprograms and converts diabetogenic T cells to Foxp3+ regulatory T cells.

Authors:  Ding Wang; Hanjun Qin; Weiting Du; Yueh-Wei Shen; Wen-Hui Lee; Arthur D Riggs; Chih-Pin Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

6.  Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells.

Authors:  Gabriela Maria Wiedemann; Max Martin Ludwig Knott; Viola Katharina Vetter; Moritz Rapp; Sascha Haubner; Julia Fesseler; Benjamin Kühnemuth; Patrick Layritz; Raffael Thaler; Stephan Kruger; Steffen Ormanns; Doris Mayr; Stefan Endres; David Anz
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

7.  Aspirin ameliorates experimental autoimmune encephalomyelitis through interleukin-11-mediated protection of regulatory T cells.

Authors:  Susanta Mondal; Malabendu Jana; Sridevi Dasarathi; Avik Roy; Kalipada Pahan
Journal:  Sci Signal       Date:  2018-11-27       Impact factor: 8.192

8.  Myelin basic protein priming reduces the expression of Foxp3 in T cells via nitric oxide.

Authors:  Saurav Brahmachari; Kalipada Pahan
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

Review 9.  T-cell regulation by CD46 and its relevance in multiple sclerosis.

Authors:  Anne L Astier
Journal:  Immunology       Date:  2008-04-02       Impact factor: 7.397

10.  Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease.

Authors:  Sheng F Cai; Xuefang Cao; Anjum Hassan; Todd A Fehniger; Timothy J Ley
Journal:  Blood       Date:  2009-11-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.